カテゴリー： 世界, 医療/バイオ, LP Information

世界のアルミニウムアジュバントワクチン市場予測 2023年-2029年

【英語タイトル】Global Aluminum Adjuvanted Vaccines Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09943）・商品コード：LP23DC09943
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：99
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアルミニウムアジュバントワクチン市場」は、過去の販売実績から2022年の世界のアルミニウムアジュバントワクチンの総販売量を検討し、2023年から2029年の予測されるアルミニウムアジュバントワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアルミニウムアジュバントワクチンの市場規模を掲載し、XXX百万米ドル規模の世界のアルミニウムアジュバントワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界のアルミニウムアジュバントワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアルミニウムアジュバントワクチン市場における各社の独自のポジションをより深く理解するために、アルミニウムアジュバントワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアルミニウムアジュバントワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アルミニウムアジュバントワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アルミニウムアジュバントワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アルミニウムアジュバントワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アルミニウムアジュバントワクチンの世界主要メーカーとしては、Emergent BioSolutions、 Sanofi、 GlaxoSmithKline Biologicals、 Pfizer、 Merck、 Wyeth Pharmaceuticalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアルミニウムアジュバントワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアルミニウムアジュバントワクチン市場をセグメンテーションし、種類別 (リン酸アルミニウム、水酸化アルミニウム、硫酸アルミニウムカリウム)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：リン酸アルミニウム、水酸化アルミニウム、硫酸アルミニウムカリウム

・用途別区分：病院、診療所

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアルミニウムアジュバントワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見たアルミニウムアジュバントワクチン市場成長の要因は何か？
・アルミニウムアジュバントワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・アルミニウムアジュバントワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アルミニウムアジュバントワクチンの年間販売量2018-2029、地域別現状・将来分析
・アルミニウムアジュバントワクチンの種類別セグメント：リン酸アルミニウム、水酸化アルミニウム、硫酸アルミニウムカリウム
・アルミニウムアジュバントワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アルミニウムアジュバントワクチンの用途別セグメント：病院、診療所
・アルミニウムアジュバントワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアルミニウムアジュバントワクチン市場
・企業別のグローバルアルミニウムアジュバントワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアルミニウムアジュバントワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別のアルミニウムアジュバントワクチン販売価格
・主要企業のアルミニウムアジュバントワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アルミニウムアジュバントワクチンの地域別レビュー
・地域別のアルミニウムアジュバントワクチン市場規模2018-2023：年間販売量、売上
・主要国別のアルミニウムアジュバントワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカのアルミニウムアジュバントワクチン販売の成長
・アジア太平洋のアルミニウムアジュバントワクチン販売の成長
・ヨーロッパのアルミニウムアジュバントワクチン販売の成長
・中東・アフリカのアルミニウムアジュバントワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別のアルミニウムアジュバントワクチン販売量、売上（2018-2023）
・南北アメリカのアルミニウムアジュバントワクチンの種類別販売量
・南北アメリカのアルミニウムアジュバントワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアルミニウムアジュバントワクチン販売量、売上（2018-2023）
・アジア太平洋のアルミニウムアジュバントワクチンの種類別販売量
・アジア太平洋のアルミニウムアジュバントワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアルミニウムアジュバントワクチン販売量、売上（2018-2023）
・ヨーロッパのアルミニウムアジュバントワクチンの種類別販売量
・ヨーロッパのアルミニウムアジュバントワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアルミニウムアジュバントワクチン販売量、売上（2018-2023）
・中東・アフリカのアルミニウムアジュバントワクチンの種類別販売量
・中東・アフリカのアルミニウムアジュバントワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アルミニウムアジュバントワクチンの製造コスト構造分析
・アルミニウムアジュバントワクチンの製造プロセス分析
・アルミニウムアジュバントワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アルミニウムアジュバントワクチンの主要なグローバル販売業者
・アルミニウムアジュバントワクチンの主要なグローバル顧客

地域別のアルミニウムアジュバントワクチン市場予測レビュー
・地域別のアルミニウムアジュバントワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アルミニウムアジュバントワクチンの種類別市場規模予測
・アルミニウムアジュバントワクチンの用途別市場規模予測

主要企業分析
Emergent BioSolutions、 Sanofi、 GlaxoSmithKline Biologicals、 Pfizer、 Merck、 Wyeth Pharmaceuticals
・企業情報
・アルミニウムアジュバントワクチン製品
・アルミニウムアジュバントワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Aluminum Adjuvanted Vaccines market size is projected to grow from US$ 635.9 million in 2022 to US$ 1211.6 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.
Vaccination programs are essential for the prevention of infectious diseases, and aluminum adjuvanted vaccines play an important role in many immunization programs. Rising awareness regarding the importance of vaccination and expanding vaccination programs across the globe is boosting the demand for aluminum adjuvanted vaccines.
The mechanism of action of aluminum adjuvant mainly includes storage effect and immunostimulatory effect. Aluminum adjuvant can also stimulate innate immunity and induce monocytes to secrete IL-1β and IL-18 by activating Nlrp3 inflammasome. In addition, aluminum adjuvant can stimulate necrotic cells at the injection site to release damage-associated pattern molecules (DAMPs) such as DNA, ATP, and uric acid, and the released DAMPs help the interaction between dendritic cells and CD4+ T cells.
LPI (LP Information)’ newest research report, the “Aluminum Adjuvanted Vaccines Industry Forecast” looks at past sales and reviews total world Aluminum Adjuvanted Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Aluminum Adjuvanted Vaccines sales for 2023 through 2029. With Aluminum Adjuvanted Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aluminum Adjuvanted Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Aluminum Adjuvanted Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aluminum Adjuvanted Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aluminum Adjuvanted Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aluminum Adjuvanted Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aluminum Adjuvanted Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Aluminum Adjuvanted Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Aluminum Phosphate
Aluminum Hydroxide
Potassium Aluminum Sulfate
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Emergent BioSolutions
Sanofi
GlaxoSmithKline Biologicals
Pfizer
Merck
Wyeth Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aluminum Adjuvanted Vaccines market?
What factors are driving Aluminum Adjuvanted Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aluminum Adjuvanted Vaccines market opportunities vary by end market size?
How does Aluminum Adjuvanted Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aluminum Adjuvanted Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aluminum Adjuvanted Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Aluminum Adjuvanted Vaccines Segment by Type
2.2.1 Aluminum Phosphate
2.2.2 Aluminum Hydroxide
2.2.3 Potassium Aluminum Sulfate
2.3 Aluminum Adjuvanted Vaccines Sales by Type
2.3.1 Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Aluminum Adjuvanted Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aluminum Adjuvanted Vaccines Sale Price by Type (2018-2023)
2.4 Aluminum Adjuvanted Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Aluminum Adjuvanted Vaccines Sales by Application
2.5.1 Global Aluminum Adjuvanted Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Aluminum Adjuvanted Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aluminum Adjuvanted Vaccines Sale Price by Application (2018-2023)
3 Global Aluminum Adjuvanted Vaccines by Company
3.1 Global Aluminum Adjuvanted Vaccines Breakdown Data by Company
3.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Aluminum Adjuvanted Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Company (2018-2023)
3.2.2 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Aluminum Adjuvanted Vaccines Sale Price by Company
3.4 Key Manufacturers Aluminum Adjuvanted Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aluminum Adjuvanted Vaccines Product Location Distribution
3.4.2 Players Aluminum Adjuvanted Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aluminum Adjuvanted Vaccines by Geographic Region
4.1 World Historic Aluminum Adjuvanted Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aluminum Adjuvanted Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Aluminum Adjuvanted Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aluminum Adjuvanted Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aluminum Adjuvanted Vaccines Sales Growth
4.4 APAC Aluminum Adjuvanted Vaccines Sales Growth
4.5 Europe Aluminum Adjuvanted Vaccines Sales Growth
4.6 Middle East & Africa Aluminum Adjuvanted Vaccines Sales Growth
5 Americas
5.1 Americas Aluminum Adjuvanted Vaccines Sales by Country
5.1.1 Americas Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
5.1.2 Americas Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
5.2 Americas Aluminum Adjuvanted Vaccines Sales by Type
5.3 Americas Aluminum Adjuvanted Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aluminum Adjuvanted Vaccines Sales by Region
6.1.1 APAC Aluminum Adjuvanted Vaccines Sales by Region (2018-2023)
6.1.2 APAC Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023)
6.2 APAC Aluminum Adjuvanted Vaccines Sales by Type
6.3 APAC Aluminum Adjuvanted Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aluminum Adjuvanted Vaccines by Country
7.1.1 Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
7.1.2 Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
7.2 Europe Aluminum Adjuvanted Vaccines Sales by Type
7.3 Europe Aluminum Adjuvanted Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aluminum Adjuvanted Vaccines by Country
8.1.1 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Type
8.3 Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aluminum Adjuvanted Vaccines
10.3 Manufacturing Process Analysis of Aluminum Adjuvanted Vaccines
10.4 Industry Chain Structure of Aluminum Adjuvanted Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aluminum Adjuvanted Vaccines Distributors
11.3 Aluminum Adjuvanted Vaccines Customer
12 World Forecast Review for Aluminum Adjuvanted Vaccines by Geographic Region
12.1 Global Aluminum Adjuvanted Vaccines Market Size Forecast by Region
12.1.1 Global Aluminum Adjuvanted Vaccines Forecast by Region (2024-2029)
12.1.2 Global Aluminum Adjuvanted Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aluminum Adjuvanted Vaccines Forecast by Type
12.7 Global Aluminum Adjuvanted Vaccines Forecast by Application
13 Key Players Analysis
13.1 Emergent BioSolutions
13.1.1 Emergent BioSolutions Company Information
13.1.2 Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Emergent BioSolutions Main Business Overview
13.1.5 Emergent BioSolutions Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GlaxoSmithKline Biologicals
13.3.1 GlaxoSmithKline Biologicals Company Information
13.3.2 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Biologicals Main Business Overview
13.3.5 GlaxoSmithKline Biologicals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.5.3 Merck Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Wyeth Pharmaceuticals
13.6.1 Wyeth Pharmaceuticals Company Information
13.6.2 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
13.6.3 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Wyeth Pharmaceuticals Main Business Overview
13.6.5 Wyeth Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Aluminum Adjuvanted Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aluminum Adjuvanted Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Aluminum Phosphate
Table 4. Major Players of Aluminum Hydroxide
Table 5. Major Players of Potassium Aluminum Sulfate
Table 6. Global Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 7. Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
Table 8. Global Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023) & ($ million)
Table 9. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2023)
Table 10. Global Aluminum Adjuvanted Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 12. Global Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2023)
Table 13. Global Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023)
Table 14. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2023)
Table 15. Global Aluminum Adjuvanted Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Aluminum Adjuvanted Vaccines Sales by Company (2018-2023) & (K Units)
Table 17. Global Aluminum Adjuvanted Vaccines Sales Market Share by Company (2018-2023)
Table 18. Global Aluminum Adjuvanted Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Company (2018-2023)
Table 20. Global Aluminum Adjuvanted Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Aluminum Adjuvanted Vaccines Producing Area Distribution and Sales Area
Table 22. Players Aluminum Adjuvanted Vaccines Products Offered
Table 23. Aluminum Adjuvanted Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Aluminum Adjuvanted Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Aluminum Adjuvanted Vaccines Sales Market Share Geographic Region (2018-2023)
Table 28. Global Aluminum Adjuvanted Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Aluminum Adjuvanted Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Aluminum Adjuvanted Vaccines Sales Market Share by Country/Region (2018-2023)
Table 32. Global Aluminum Adjuvanted Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 35. Americas Aluminum Adjuvanted Vaccines Sales Market Share by Country (2018-2023)
Table 36. Americas Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Aluminum Adjuvanted Vaccines Revenue Market Share by Country (2018-2023)
Table 38. Americas Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 39. Americas Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 40. APAC Aluminum Adjuvanted Vaccines Sales by Region (2018-2023) & (K Units)
Table 41. APAC Aluminum Adjuvanted Vaccines Sales Market Share by Region (2018-2023)
Table 42. APAC Aluminum Adjuvanted Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Aluminum Adjuvanted Vaccines Revenue Market Share by Region (2018-2023)
Table 44. APAC Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 45. APAC Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 46. Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Country (2018-2023)
Table 48. Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Aluminum Adjuvanted Vaccines Revenue Market Share by Country (2018-2023)
Table 50. Europe Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 51. Europe Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Aluminum Adjuvanted Vaccines Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Aluminum Adjuvanted Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Aluminum Adjuvanted Vaccines Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Aluminum Adjuvanted Vaccines Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Aluminum Adjuvanted Vaccines
Table 59. Key Market Challenges & Risks of Aluminum Adjuvanted Vaccines
Table 60. Key Industry Trends of Aluminum Adjuvanted Vaccines
Table 61. Aluminum Adjuvanted Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Aluminum Adjuvanted Vaccines Distributors List
Table 64. Aluminum Adjuvanted Vaccines Customer List
Table 65. Global Aluminum Adjuvanted Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Aluminum Adjuvanted Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Aluminum Adjuvanted Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Aluminum Adjuvanted Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Aluminum Adjuvanted Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Aluminum Adjuvanted Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Aluminum Adjuvanted Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Aluminum Adjuvanted Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Aluminum Adjuvanted Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Aluminum Adjuvanted Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Aluminum Adjuvanted Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Aluminum Adjuvanted Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Aluminum Adjuvanted Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Aluminum Adjuvanted Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Emergent BioSolutions Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 81. Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Emergent BioSolutions Main Business
Table 83. Emergent BioSolutions Latest Developments
Table 84. Sanofi Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 86. Sanofi Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. GlaxoSmithKline Biologicals Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 91. GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. GlaxoSmithKline Biologicals Main Business
Table 93. GlaxoSmithKline Biologicals Latest Developments
Table 94. Pfizer Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 96. Pfizer Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Merck Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 101. Merck Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Wyeth Pharmaceuticals Basic Information, Aluminum Adjuvanted Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Portfolios and Specifications
Table 106. Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Wyeth Pharmaceuticals Main Business
Table 108. Wyeth Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Aluminum Adjuvanted Vaccines
Figure 2. Aluminum Adjuvanted Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aluminum Adjuvanted Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aluminum Adjuvanted Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aluminum Adjuvanted Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Aluminum Phosphate
Figure 10. Product Picture of Aluminum Hydroxide
Figure 11. Product Picture of Potassium Aluminum Sulfate
Figure 12. Global Aluminum Adjuvanted Vaccines Sales Market Share by Type in 2022
Figure 13. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2023)
Figure 14. Aluminum Adjuvanted Vaccines Consumed in Hospital
Figure 15. Global Aluminum Adjuvanted Vaccines Market: Hospital (2018-2023) & (K Units)
Figure 16. Aluminum Adjuvanted Vaccines Consumed in Clinic
Figure 17. Global Aluminum Adjuvanted Vaccines Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Aluminum Adjuvanted Vaccines Sales Market Share by Application (2022)
Figure 19. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Application in 2022
Figure 20. Aluminum Adjuvanted Vaccines Sales Market by Company in 2022 (K Units)
Figure 21. Global Aluminum Adjuvanted Vaccines Sales Market Share by Company in 2022
Figure 22. Aluminum Adjuvanted Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Company in 2022
Figure 24. Global Aluminum Adjuvanted Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Aluminum Adjuvanted Vaccines Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Aluminum Adjuvanted Vaccines Sales 2018-2023 (K Units)
Figure 27. Americas Aluminum Adjuvanted Vaccines Revenue 2018-2023 ($ Millions)
Figure 28. APAC Aluminum Adjuvanted Vaccines Sales 2018-2023 (K Units)
Figure 29. APAC Aluminum Adjuvanted Vaccines Revenue 2018-2023 ($ Millions)
Figure 30. Europe Aluminum Adjuvanted Vaccines Sales 2018-2023 (K Units)
Figure 31. Europe Aluminum Adjuvanted Vaccines Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Aluminum Adjuvanted Vaccines Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Aluminum Adjuvanted Vaccines Revenue 2018-2023 ($ Millions)
Figure 34. Americas Aluminum Adjuvanted Vaccines Sales Market Share by Country in 2022
Figure 35. Americas Aluminum Adjuvanted Vaccines Revenue Market Share by Country in 2022
Figure 36. Americas Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
Figure 37. Americas Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2023)
Figure 38. United States Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Aluminum Adjuvanted Vaccines Sales Market Share by Region in 2022
Figure 43. APAC Aluminum Adjuvanted Vaccines Revenue Market Share by Regions in 2022
Figure 44. APAC Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
Figure 45. APAC Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2023)
Figure 46. China Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Country in 2022
Figure 54. Europe Aluminum Adjuvanted Vaccines Revenue Market Share by Country in 2022
Figure 55. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
Figure 56. Europe Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2023)
Figure 57. Germany Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Aluminum Adjuvanted Vaccines Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Aluminum Adjuvanted Vaccines Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2023)
Figure 66. Egypt Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Aluminum Adjuvanted Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Aluminum Adjuvanted Vaccines in 2022
Figure 72. Manufacturing Process Analysis of Aluminum Adjuvanted Vaccines
Figure 73. Industry Chain Structure of Aluminum Adjuvanted Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Aluminum Adjuvanted Vaccines Sales Market Forecast by Region (2024-2029)
Figure 76. Global Aluminum Adjuvanted Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Aluminum Adjuvanted Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Aluminum Adjuvanted Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Aluminum Adjuvanted Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Aluminum Adjuvanted Vaccines Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアルミニウムアジュバントワクチン市場予測 2023年-2029年] (コード：LP23DC09943)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアルミニウムアジュバントワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗破傷風血清市場予測 2023年-2029年
  • 世界のアルミ合金製小型バイブレータ市場予測 2023年-2029年
  • 世界のアルミニウム炭化ケイ素ヒートシンク市場予測 2023年-2029年
  • 世界の熱交換器用アルミニウム合金市場予測 2023年-2029年
  • 世界のアルミリニアレール市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆